Literature DB >> 718867

Binding of bovine coagulation factor Xa to platelets.

B Dahlbäck, J Stenflo.   

Abstract

The binding of highly purified bovine coagulation factor Xa to washed bovine platelets was studied. 125I-labeled factor Xa underwent binding to a platelet receptor that became accessible only after induction of the platelet release reaction by thrombin or by the calcium ionophore A 23187. The zymogen factor X did not bind to platelets. The factor Xa binding was saturable, reversible, and correlated with the rate of thrombin formation. The number of factor Xa binding sites per platelet was 290--420 and the apparent association constant was estimated to be 2.8 x 109 to 1.0 x 1010 M-1. Diisoprophyl fluorophosphate-factor Xa bound to the same platelet receptor as factor Xa indicating that limited proteolysis of a receptor protein was not required for binding. The rate of factor Xa binding was rapid (2.1 x 10(6) to 2.9 x 10(6) M-1 s-1) and similar to that preveiously found for the rate of binding of polypeptide hormones to their receptors. Displacement of factor Xa from the platelet receptor by diisopropyl fluorophosphate-factor Xa effectively blocked thrombin formation. Low concentrations of factor Xa catalyze prothrombin activation more effectively in the presence of platelets than in the presence of phospholipid and factor V.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718867     DOI: 10.1021/bi00616a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

Authors:  S S Ahmad; R Rawala-Sheikh; B Ashby; P N Walsh
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  An endothelial cell-dependent pathway of coagulation.

Authors:  D Stern; P Nawroth; D Handley; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

Authors:  B S Schwartz; G A Levy; L K Curtiss; D S Fair; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

Authors:  D M Stern; P P Nawroth; W Kisiel; D Handley; M Drillings; J Bartos
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Human coagluation factor V purification and thrombin-catalyzed activation.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  Protection of factor Xa from neutralization by the heparin-antithrombin complex.

Authors:  J M Teitel; R D Rosenberg
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.

Authors:  Mårten Steen; Sinh Tran; Ludovic Autin; Bruno O Villoutreix; Ann-Louise Tholander; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

9.  The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly.

Authors:  Raffaella Toso; Hua Zhu; Rodney M Camire
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

10.  The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides.

Authors:  T W Barrowcliffe; S J Havercroft; G Kemball-Cook; U Lindahl
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.